Fuente: Fortune
AstraZeneca will pay $425 million upfront for EsoBiotec and may spend up to $575 million more in development and regulatory milestones, the companies said.
Leer en la Fuente
Noticias Relacionadas
Fuente: Fortune
AstraZeneca will pay $425 million upfront for EsoBiotec and may spend up to $575 million more in development and regulatory milestones, the companies said.